Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01248572 · ClinicalTrials.gov registry record · Phase 4
Evaluation of Effective Lens Position With a Uniplanar Bi-aspheric IOL
A Phase 4 study of Cataract, sponsored by Lenstec Incorporated.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
- 3
- Study locations
NCT01248572 is a Phase 4 study of Cataract that has completed, run by Lenstec Incorporated. The registered enrollment target is 40 participants, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (82% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT01248572, a Phase 4 study of Cataract, has completed, sponsored by Lenstec Incorporated.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
- 3
- Study locations
Study Summary
The primary goal of this study is to determine the effective lens position (ELP) - or location an intraocular lens (IOL) "sits" in the eye - of the Softec HD IOL. A secondary study goal is to determine if measures of the eye taken prior to surgery can reliably predict postoperative ELP.
Conditions Studied
Interventions
- DEVICE Softec HD IOL
Study Locations (3)
Arizona
- Barnet-Dulaney-Perkins Eye Center - Phoenix
Florida
- Eye Centers of Florida - Fort Myers
Georgia
- Harbin Clinic - Rome
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2010-10 |
| Est. Completion | 2012-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01248572
The ClinicalTrials.gov registry entry for NCT01248572 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (82% lower). The listed sponsor is Lenstec Incorporated, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cataract appearing as the primary indexed condition, and to 1 intervention - of which Softec HD IOL is the first listed.
NCT01248572 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Arizona, Florida, Georgia.
Frequently Asked Questions
What is clinical trial NCT01248572 about?
NCT01248572 is a clinical study titled "Evaluation of Effective Lens Position With a Uniplanar Bi-aspheric IOL". The primary goal of this study is to determine the effective lens position (ELP) - or location an intraocular lens (IOL) "sits" in the eye - of the Softec HD IOL. A secondary study goal is to determine if measures of the eye taken prior to surgery can reliably predict postoperative ELP.
What is the current status of trial NCT01248572?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2010-10. Estimated completion is 2012-03.
What conditions does trial NCT01248572 study?
This clinical trial studies the following conditions: Cataract.
What interventions are being tested in trial NCT01248572?
The interventions under investigation include: Softec HD IOL (DEVICE).
Who is sponsoring clinical trial NCT01248572?
This trial is sponsored by Lenstec Incorporated, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01248572 being conducted?
This trial has 3 study locations across Arizona, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cataract
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluating a Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population
RECRUITING · Phase 4
-
A Prospective, Randomized, Subject and Vision-assessor Masked, Multicenter Study Comparing Bilateral Clareon PanOptix, Bilateral Clareon PanOptix Pro, and Mixed Clareon PanOptix Pro/Vivity Intraocular Lens Implantation in Cataract Subjects
RECRUITING · Phase 4
-
Evaluation of a Monofocal Intraocular Lens
RECRUITING · Phase 4
-
Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract
RECRUITING · Phase 4
-
Odyssey Evaluation in Post LASIK Patients
RECRUITING · Phase 4
-
Dropless vs. Standard Drops Contralateral Eye Study
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.